RE: Morning all ..7 Jun 2021 12:09
Indeed, reiterated in today’s RNS
“ The Company continues to progress the Modi-1 Phase 1/2 clinical trial for regulatory submission to start the planned clinical study in the UK in the first half of 2021.”
Only 3 weeks left, should be a very news heavy month ahead !